These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 18324365)
21. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis. Blankenberg FG; Vanderheyden JL; Strauss HW; Tait JF Nat Protoc; 2006; 1(1):108-10. PubMed ID: 17406220 [TBL] [Abstract][Full Text] [Related]
22. Near-infrared fluorescent imaging of tumor apoptosis. Petrovsky A; Schellenberger E; Josephson L; Weissleder R; Bogdanov A Cancer Res; 2003 Apr; 63(8):1936-42. PubMed ID: 12702586 [TBL] [Abstract][Full Text] [Related]
23. Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. Kietselaer BL; Reutelingsperger CP; Boersma HH; Heidendal GA; Liem IH; Crijns HJ; Narula J; Hofstra L J Nucl Med; 2007 Apr; 48(4):562-7. PubMed ID: 17401092 [TBL] [Abstract][Full Text] [Related]
24. Rhodamine B isothiocyanate doped silica-coated fluorescent nanoparticles (RBITC-DSFNPs)-based bioprobes conjugated to Annexin V for apoptosis detection and imaging. Shi H; He X; Wang K; Yuan Y; Deng K; Chen J; Tan W Nanomedicine; 2007 Dec; 3(4):266-72. PubMed ID: 17988954 [TBL] [Abstract][Full Text] [Related]
25. Advanced carotid plaque imaging. Hermus L; van Dam GM; Zeebregts CJ Eur J Vasc Endovasc Surg; 2010 Feb; 39(2):125-33. PubMed ID: 20031452 [TBL] [Abstract][Full Text] [Related]
29. The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging. Kietselaer BL; Hofstra L; Dumont EA; Reutelingsperger CP; Heidendal GA Q J Nucl Med; 2003 Dec; 47(4):349-61. PubMed ID: 14973424 [TBL] [Abstract][Full Text] [Related]
30. Eukaryotic expression and secretion of EGFP-labeled annexin A5. Stöcker M; Pardo A; Hetzel C; Reutelingsperger C; Fischer R; Barth S Protein Expr Purif; 2008 Apr; 58(2):325-31. PubMed ID: 18261921 [TBL] [Abstract][Full Text] [Related]
31. Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Corsten MF; Hofstra L; Narula J; Reutelingsperger CP Cancer Res; 2006 Feb; 66(3):1255-60. PubMed ID: 16452175 [TBL] [Abstract][Full Text] [Related]
34. Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. Laufer EM; Winkens MH; Narula J; Hofstra L Arterioscler Thromb Vasc Biol; 2009 Jul; 29(7):1031-8. PubMed ID: 19461053 [TBL] [Abstract][Full Text] [Related]
35. Role of imaging in cardiac stem cell therapy. Beeres SL; Bengel FM; Bartunek J; Atsma DE; Hill JM; Vanderheyden M; Penicka M; Schalij MJ; Wijns W; Bax JJ J Am Coll Cardiol; 2007 Mar; 49(11):1137-48. PubMed ID: 17367656 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells. Ernst JD; Yang L; Rosales JL; Broaddus VC Anal Biochem; 1998 Jun; 260(1):18-23. PubMed ID: 9648647 [TBL] [Abstract][Full Text] [Related]
37. Past, present, and future of annexin A5: from protein discovery to clinical applications. Boersma HH; Kietselaer BL; Stolk LM; Bennaghmouch A; Hofstra L; Narula J; Heidendal GA; Reutelingsperger CP J Nucl Med; 2005 Dec; 46(12):2035-50. PubMed ID: 16330568 [TBL] [Abstract][Full Text] [Related]
39. Molecular imaging of cell death. De Saint-Hubert M; Prinsen K; Mortelmans L; Verbruggen A; Mottaghy FM Methods; 2009 Jun; 48(2):178-87. PubMed ID: 19362149 [TBL] [Abstract][Full Text] [Related]
40. Purification of annexin V and its use in the detection of apoptotic cells. Coxon KM; Duggan J; Cordeiro MF; Moss SE Methods Mol Biol; 2011; 731():293-308. PubMed ID: 21516416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]